Catalyst Calendar - Japan Equity June 11 Issue

Research evidence excerpt

Catalyst Calendar - Japan Equity June 11 Issue

J P M O R G A N Asia Pacific Equity Research

11 June 2026

Catalyst Calendar - Japan Equity

June 11 Issue

Main Events Japan Equity Research

Japan Equity Research

AC• June 25 (Thursday) Oracle Japan (4716, Overweight, Matthew Japan Research

Henderson) 4Q FY2025 earnings announcement: We expect the EPS range japanresearch@jpmorgan.com

in guidance for FY2026 will be +6% to +10% YoY. If an increase in the AC Akira Kishimoto

dividend payout ratio is also announced, it would be a positive surprise. (81-3) 6736-8646

• June 26 (Friday) Asahi Intecc (7747, Overweight, Naoko Saito) Thailand akira.x.kishimoto@jpmorgan.com

factory tour: The company has made productivity improvement at its JPMorgan Securities Japan Co., Ltd.

factories one of the themes of its medium-term plan, and productivity has

continued to improve steadily in FY6/26. The tour will introduce specific

initiatives to improve productivity. As FY6/26 earnings have been quite strong,

the hurdle for FY6/27 is rising, but if the tour confirms the company’s strengths

in productivity improvement, we believe this could lead to an increase in sell-

side consensus earnings estimates.

• June-August 2026: Otsuka Holdings (4578, Overweight, Seiji Wakao)

Announcement of Ph3 eGFR top-line data for sibeprenlimab: If favorable

data showing sufficient maintenance or improvement of kidney function is

obtained, this could accelerate market penetration and be positive for the stock.

• August 24 (Monday) Eisai (4523, Neutral, Seiji Wakao) Decision on

approval for Leqembi SC-AI initiation: Approval is the consensus view, but

if approval is announced, we believe confidence in profit growth driven by

Leqembi would increase and the share price would rise.